@bowerman you did well to hold off on what must have been a twitchy trigger finger to here.
As I and others have seen in another tech, success or failure is always so binary. I look at bio-techs like call options. If they make it, they light up (as MSB did in 2020 and who'd have thought then, they'd be four and zero). I have no loathing for shorts. They took substantial risk and it paid off. This recent selling in June is all about EOFY in my opinion. I am happily buying more down here, but I've had winners elsewhere, not least of which getting out of US tech mid 2021 and shorting US mkt from late 2021 - happily buying Aussie and US bio-techs in a sector that has been crushed:
@bowerman you did well to hold off on what must have been a...
-
- There are more pages in this discussion • 357 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
-0.065(6.07%) |
Mkt cap ! $1.147B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.05 | 99.5¢ | $9.449M | 9.298M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 64999 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.02 | 64541 | 3 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |